Assuta Ashdod University Hospital, Israel.
Tel Aviv Sourasky Medical Center, Israel.
J Atten Disord. 2022 Jul;26(9):1235-1244. doi: 10.1177/10870547211068039. Epub 2021 Dec 21.
To assess the correlation of co-morbid ADHD and diabetes-related complications in patients with type-1-diabetes-mellitus (T1DM).
A retrospective cross-sectional study was conducted during 2018 using the Leumit-Health-Services(LHS) database. Diabetes-related complications were assessed in patients with T1DM and ADHD (T1DM-ADHD+) and compared with patients with T1DM alone (T1DM-ADHD-).
Out of 789 adult-patients with T1DM, 75 (9.5%) were T1DM-ADHD+, matched to 225 T1DM-ADHD-. HbAC levels were higher in T1DM-ADHD+ patients (8.1% ± 1.6 vs. 7.4% ± 1.2, < .01), as well as diabetes-related complications: neuropathy (22.7% vs. 5.8%, < .01), ulcers (8% vs. 0.9%, < .05), limb amputation (5.3% vs. 0.9%, < .05), albuminuria (15.5% vs. 2.8%, < .01), chronic renal failure (10.6% vs. 2.5%, = .01), and emergency room admissions rate (26.7% vs. 15.1%, < .05). In sub-analysis, lower average HbAC levels and diabetic ulcer rates were found among ADHD patients treated with stimulants, all < .05.
Co-morbidity of ADHD and T1DM is associated with poor glycemic control and higher complication rates.
评估患有 1 型糖尿病(T1DM)的患者共患注意力缺陷多动障碍(ADHD)与糖尿病相关并发症的相关性。
2018 年,我们进行了一项回顾性的横断面研究,使用 Leumit-Health-Services(LHS)数据库。在患有 T1DM 和 ADHD(T1DM-ADHD+)的患者中评估糖尿病相关并发症,并与仅患有 T1DM 的患者(T1DM-ADHD-)进行比较。
在 789 名成年 T1DM 患者中,75 名(9.5%)为 T1DM-ADHD+,与 225 名 T1DM-ADHD-患者相匹配。T1DM-ADHD+患者的 HbAC 水平更高(8.1%±1.6 与 7.4%±1.2, < .01),且糖尿病相关并发症的发生率也更高:神经病变(22.7%与 5.8%, < .01)、溃疡(8%与 0.9%, < .05)、肢体截肢(5.3%与 0.9%, < .05)、白蛋白尿(15.5%与 2.8%, < .01)、慢性肾衰竭(10.6%与 2.5%, = .01)和急诊入院率(26.7%与 15.1%, < .05)。在亚分析中,我们发现接受兴奋剂治疗的 ADHD 患者的平均 HbAC 水平和糖尿病溃疡发生率较低,均 < .05。
ADHD 与 T1DM 共病与血糖控制不佳和更高的并发症发生率相关。